-transparent.png){kind=logo}
Evaluation of plasma exosomal microRNAs as circulating biomarkers for progression and metastasis of gastric cancer. 2020
Yuqi Chen, and
Huang Feng, and
Yanlin Wu, and
Ruoqin Wang, and
Zhaoji Li, and
Jiajia Chen, and
Wenying Yan, and
Weichang Chen
Department of Gastroenterology, The First Affiliated Hospital of Soochow University, Suzhou, China.
| UI | MeSH Term | Description | Entries |
|---|
Related Publications
Yuqi Chen, and
Huang Feng, and
Yanlin Wu, and
Ruoqin Wang, and
Zhaoji Li, and
Jiajia Chen, and
Wenying Yan, and
Weichang Chen
January 2014,
PloS one,
Yuqi Chen, and
Huang Feng, and
Yanlin Wu, and
Ruoqin Wang, and
Zhaoji Li, and
Jiajia Chen, and
Wenying Yan, and
Weichang Chen
February 2017,
Cancer gene therapy,
Yuqi Chen, and
Huang Feng, and
Yanlin Wu, and
Ruoqin Wang, and
Zhaoji Li, and
Jiajia Chen, and
Wenying Yan, and
Weichang Chen
January 2020,
Disease markers,
Yuqi Chen, and
Huang Feng, and
Yanlin Wu, and
Ruoqin Wang, and
Zhaoji Li, and
Jiajia Chen, and
Wenying Yan, and
Weichang Chen
August 2018,
Melanoma research,
Yuqi Chen, and
Huang Feng, and
Yanlin Wu, and
Ruoqin Wang, and
Zhaoji Li, and
Jiajia Chen, and
Wenying Yan, and
Weichang Chen
January 2023,
Frontiers in immunology,
Yuqi Chen, and
Huang Feng, and
Yanlin Wu, and
Ruoqin Wang, and
Zhaoji Li, and
Jiajia Chen, and
Wenying Yan, and
Weichang Chen
February 2017,
Oncotarget,
Yuqi Chen, and
Huang Feng, and
Yanlin Wu, and
Ruoqin Wang, and
Zhaoji Li, and
Jiajia Chen, and
Wenying Yan, and
Weichang Chen
August 2020,
Oncology letters,
Yuqi Chen, and
Huang Feng, and
Yanlin Wu, and
Ruoqin Wang, and
Zhaoji Li, and
Jiajia Chen, and
Wenying Yan, and
Weichang Chen
January 2020,
Clinics (Sao Paulo, Brazil),
Yuqi Chen, and
Huang Feng, and
Yanlin Wu, and
Ruoqin Wang, and
Zhaoji Li, and
Jiajia Chen, and
Wenying Yan, and
Weichang Chen
January 2019,
Frontiers in oncology,
Yuqi Chen, and
Huang Feng, and
Yanlin Wu, and
Ruoqin Wang, and
Zhaoji Li, and
Jiajia Chen, and
Wenying Yan, and
Weichang Chen
February 2021,
Oncology letters,
